Fecal Microbiota Spores, Live-Brpk Interactions

Brand names: Vowst

Route: Oral

Contraindications

4 CONTRAINDICATIONS None . None. ( 4 )

Pregnancy & Breastfeeding

8.1 Pregnancy Risk Summary All pregnancies have a background risk of major birth defect, loss, or other adverse outcomes. In the U.S. general population, the estimated background risk of major birth defects and miscarriages in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively. There are no data on use of VOWST in pregnant individuals. Developmental toxicity studies in animals have not been conducted with VOWST.

1 interaction on record